The series B round equips Amphora to take its minimally invasive, cystoscopic device into the last step of clinical development next year.

Simplify Medical raised $21 million in series B funding to support two U.S. pivotal trials of its nonmetal cervical artificial disc.

BGI Genomics has completed its IPO, giving it cash at a time when it is trying to establish itself as a major player in biomedical testing.

Allurion Technologies has raised $27 million in series C funding for its swallowable, procedureless, weight-loss balloon.

Axonics Modulation Technologies raised $20.5 million in the second closing of its series C financing.

Creavo Medical Technologies has raised $17 million to develop its heart attack test.

Digital diabetes management player Glooko raised $35 million to further develop its technology and expand in a number of markets.

SerImmune, whose technology maps the human antibody repertoire, rounded up $8 million from Merck, Illumina Ventures and unnamed investors.

Mindstrong Health raised $14 million in its Series A, which it will use to build out its technology and clinical operations teams.